mo:re GmbH

mo:re is a biotech startup dedicated to revolutionizing the pharmaceutical industry. Founded in 2023 and based in Hamburg, we are on a mission to establish the new gold standard for organoid-based drug development, ultimately aiming to eliminate the need for animal studies. Our innovative lab platform empowers organizations to conduct organoid cell culture studies, offering a cost-effective, faster, and more compliant alternative to traditional animal testing.

Pharma, Biotechnology

Having closed our Seed Funding round, we will begin the commercialization of our product in Q4 2024. For this, our software platform needs to be expanded.